Retatrutide is a novel triple agonist peptide that activates GIP, GLP-1, and glucagon receptors. This advanced research compound is being extensively studied for its potential effects on weight management, metabolic health, and energy expenditure in research models.
AOD-9604 is a modified fragment of human growth hormone (HGH) specifically desig...